Asger R. Bihlet , MSc

Asger R. Bihlet is a seasoned osteoarthritis clinical development expert. Holding a MSc. degree from Copenhagen University, Asger has wide experience from several areas of the pharmaceutical industry including medical affairs, regulatory affairs, and clinical development.

Asger has played a pivotal role in several global clinical drug development programs, and has represented multiple companies and consortia in interactions with European regulatory agencies and the FDA. Asger is actively researching and publishing in the field of osteoarthritis, with a particular focus on OA biomarkers, and improving clinical trial design and outcomes.